GeneproDX
PrivateLast Round
Early Funding
Feb 14, 2022
Est. Valuation
$135M
Total Funding Raised
$2.34M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GeneproDX is a biotechnology company that develops molecular diagnostic tests, including the ThyroidPrint genomic classifier, to aid in the management of indeterminate thyroid nodules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneproDX Comparables
Compare GeneproDX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biocartis | 80% | |
| Sonic Healthcare | 74% | |
| Veracyte | 72% |
GeneproDX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 14, 2022 | ||||
| VC Round | Apr 17, 2018 | ||||
| VC Round | Dec 12, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 153% MoM.
- Mar 2, 2026
Monthly visitors increased 34% MoM.
GeneproDX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneproDX's valuation, stock price, and market status.
Is GeneproDX a public or private company?
GeneproDX is a private company.
What is the current stock price of GeneproDX?
GeneproDX is a private company with no public stock price. No recent secondary market data is available.
How much is GeneproDX worth (valuation)?
GeneproDX's valuation is estimated at $135.0M based on funding round data.
Can I buy GeneproDX stock?
GeneproDX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GeneproDX's last funding round?
GeneproDX's most recent funding round was VC Round on February 14, 2022.
Who are the main investors in GeneproDX?
Key investors in GeneproDX include Venturance, Endurance Investments.
Will GeneproDX IPO soon?
No public IPO plans have been announced for GeneproDX.
How can I track GeneproDX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneproDX's secondary market activity and sign up for updates.